CLINICAL_TRIALS
research
· 2025-12-22
Clinical Trial Update: The Effect of Topical Imipramine on Photodynamic Therapy-Mediated Immunosuppression on Forearms or Face on US Veterans [Phase 2]
Summary
A Phase 2 trial is evaluating whether topical imipramine can influence photodynamic therapy-mediated immunosuppression in actinic keratosis lesions on the forea…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: VA Office of Research and Development | Conditions: Actinic Keratosis, Imipramine | Phase 2 | Status: RECRUITING